RADIOIMMUNOASSAY MARKET ANALYSIS

Regional Analysis

Radioimmunoassay Market – Regional Insights

On the basis of region, radioimmunoassay market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America holds dominant position in the market, owing to rising adoption of technologically advanced devices, awareness among the people, high infection rates, better medical facilities, and rising adoption of innovative products. Moreover, government support towards the infection-free states is also increasing growth of radioimmunoassay market. For instance, according to 2015 National Ambulatory Medical Care survey, 16.8 million number of visits to physician offices for infectious and parasitic diseases were recorded.

Asia Pacific is expected to witness significant growth in the market over the forecast period, owing to large number of population vulnerable to various chronic diseases and increasing healthcare research activities. For instance, the World Health Organization (WHO) report in 2011 estimates that around 37% of perinatal conditions, 35% of nutritional deficiencies, 33% of maternal conditions, 30% of respiratory infections, and 27% of the global burden of infectious and parasitic diseases are prevalent in this region.